Literature DB >> 6307869

Impaired autonomic responsiveness of the cardiovascular system of the rat induced by a heat-labile component of Bordetella pertussis vaccine.

D J de Wildt, H G Kreeftenberg, F P Nijkamp.   

Abstract

Bordetella pertussis vaccination induces severe impairment of the autonomic responsiveness of the cardiovascular system in rats. The vasodilation after beta 2-adrenoceptor stimulation with salbutamol as well as the negative chronotropic action induced by the muscarinic receptor stimulant arecoline were inhibited 4 days after vaccination. Moreover, basal blood pressure values appeared to be significantly lower in B. pertussis-vaccinated rats compared with control animals. These effects were dependent upon the bacterial strain used. Differences in pharmacological activity due to strain differences paralleled variations in the content of lymphocytosis-promoting factor of the vaccine. The inhibitory effects were absent after the administration of vaccine heated for 1 h at 80 degrees C, implicating an important role for a heat-labile component, e.g., lymphocytosis-promoting factor, and not for a heat-stable constituent, e.g., endotoxin (lipopolysaccharide). Previous studies indicate that some early biological effects elicited by B. pertussis vaccine can be attributed to lipopolysaccharide, whereas late induced effects are mainly brought about by lymphocytosis-promoting factor. For that reason a role for lipopolysaccharide might be excluded because 5 h after vaccination no disturbances of the autonomic nervous system were observed. We conclude that B. pertussis vaccination induces autonomic hyporesponsiveness due to a heat-labile component that is assumed to be lymphocytosis-promoting factor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307869      PMCID: PMC264665          DOI: 10.1128/iai.41.2.476-481.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Alterations in adenyl cyclase activity and glucose utilization of Bordetella pertussis-sensitized mouse spleen.

Authors:  R A Ortez; D Seshachalam; A Szentivanyi
Journal:  Biochem Pharmacol       Date:  1975-07-15       Impact factor: 5.858

Review 2.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors:  M Pittman
Journal:  Rev Infect Dis       Date:  1979 May-Jun

3.  Effects of methacholine, histamine and atropine on pulmonary guanosine-3', 5'-monophosphate levels in hypersensitive mice.

Authors:  J B Polson; J J Krzanowski; A Szentivanyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

4.  The limulus amebocyte lysate test micromethod and application in the control of sera and vaccines.

Authors:  J G Kreeftenberg; H G Loggen; J D van Ramshorst; E C Beuvery
Journal:  Dev Biol Stand       Date:  1977

5.  TV report on DTP galvanizes US pediatricians.

Authors:  E R González
Journal:  JAMA       Date:  1982-07-02       Impact factor: 56.272

6.  Severe impairment of cholinergic and adrenergic responsiveness in Bordetella pertussis vaccinated rats.

Authors:  D J De Wildt; J G Kreeftenberg; F P Nijkamp
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

7.  Pertussis.

Authors:  L C Olson
Journal:  Medicine (Baltimore)       Date:  1975-11       Impact factor: 1.889

  7 in total
  3 in total

1.  Disturbance of mice tracheal beta-adrenoceptor and cholinergic receptor function by Bordetella pertussis and its cell wall components.

Authors:  G H Veenendaal; D J Kool; D J de Wildt; F P Nijkamp
Journal:  Agents Actions       Date:  1986-12

2.  Mepyramine but not cimetidine or clobenpropit blocks pertussis toxin-induced histamine sensitization in rats.

Authors:  W Vleeming; C F Hendriksen; A van de Kuil; J W van den Hout; D J de Wildt
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 3.  Non-primate animal models for pertussis: back to the drawing board?

Authors:  Nevio Cimolai
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-01       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.